Business Description
NGeneBio Co Ltd
ISIN : KR7354200008
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.16 | |||||
Debt-to-EBITDA | -1.22 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.55 | |||||
Beneish M-Score | -1.39 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.6 | |||||
3-Year EBITDA Growth Rate | 1.4 | |||||
3-Year EPS without NRI Growth Rate | -6.1 | |||||
3-Year FCF Growth Rate | -5.3 | |||||
3-Year Book Growth Rate | -28 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 15.81 | |||||
9-Day RSI | 34.7 | |||||
14-Day RSI | 42.62 | |||||
6-1 Month Momentum % | -63.62 | |||||
12-1 Month Momentum % | -54.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.52 | |||||
Quick Ratio | 0.41 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 240.86 | |||||
Days Sales Outstanding | 66.59 | |||||
Days Payable | 20.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -1.55 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40 | |||||
Operating Margin % | -271.64 | |||||
Net Margin % | -266.29 | |||||
FCF Margin % | -236.14 | |||||
ROE % | -86.38 | |||||
ROA % | -31.39 | |||||
ROIC % | -33.01 | |||||
ROC (Joel Greenblatt) % | -123.26 | |||||
ROCE % | -68.12 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.53 | |||||
PB Ratio | 3.38 | |||||
Price-to-Tangible-Book | 10.36 | |||||
EV-to-EBIT | -3.85 | |||||
EV-to-EBITDA | -4.49 | |||||
EV-to-Revenue | 9.54 | |||||
EV-to-FCF | -4.33 | |||||
Earnings Yield (Greenblatt) % | -26.02 | |||||
FCF Yield % | -29.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NGeneBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,988.629 | ||
EPS (TTM) (â‚©) | -1036 | ||
Beta | 1.27 | ||
Volatility % | 61.16 | ||
14-Day RSI | 42.62 | ||
14-Day ATR (â‚©) | 349.36819 | ||
20-Day SMA (â‚©) | 3364 | ||
12-1 Month Momentum % | -54.22 | ||
52-Week Range (â‚©) | 2180 - 7360 | ||
Shares Outstanding (Mil) | 13.74 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NGeneBio Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NGeneBio Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
NGeneBio Co Ltd Frequently Asked Questions
What is NGeneBio Co Ltd(XKRX:354200)'s stock price today?
When is next earnings date of NGeneBio Co Ltd(XKRX:354200)?
Does NGeneBio Co Ltd(XKRX:354200) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |